Please see below for the current list of Alopecia trials being run by AvantDerm Research. If you’d like to participate, be sure to read all the details and then contact us to schedule an appointment with our research team.
PRURIGO NODULARIS | SANOFI GENZYME EFC16460
PHASE III
RECRUITING
This is a randomized, double-blind, placebo-controlled, multi-centre, parallel group study to evaluate the efficacy and safety of dupilumab in patients with prurigo nodularis who are inadequately controlled on topical prescription therapies or when those therapies are not advisable.
